SCHEMBL8525883

SCHEMBL8525883

CC(C)[C@H](NC(=O)c1cc2cc(Cc3ccccc3)ccc2n1C)C(=O)C(F)C(=O)C(N)CC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PHGDH O43175 6/20 0.41
TRPA1 O75762 1/20 0.40
GALR3 O60755 1/20 0.39
GAA P10253 1/20 0.39
ATM Q13315 1/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
POLB P06746 1/20 0.38
CTSL P07711 1/20 0.37
CTSS P25774 1/20 0.37
CNR2 P34972 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8501439 0.88 TRPA1 (0.51) MEN1KMT2APHGDHTRPA1CTSL
SCHEMBL8498375 0.87 MEN1 (0.51) MEN1KMT2AL3MBTL1PHGDHTRPA1
SCHEMBL8525886 0.80 MEN1 (0.44) MEN1KMT2AL3MBTL1PHGDHTRPA1
SCHEMBL5669358 0.79 CASP3 (0.47) MEN1KMT2AL3MBTL1TRPA1
SCHEMBL7390779 0.79 CNR2 (0.54) TRPA1CNR2TSHR
SCHEMBL7390177 0.78 CNR2 (0.43) PHGDHTRPA1CNR2TSHR
SCHEMBL7387717 0.78 CNR2 (0.50) MEN1KMT2AL3MBTL1PHGDHTRPA1
SCHEMBL7387933 0.74 TRPA1 (0.49) MEN1KMT2APHGDHTRPA1CTSL
SCHEMBL8496435 0.73 CASP1 (0.36) MEN1KMT2AL3MBTL1CNR2KDM4E
SCHEMBL7390761 0.73 KDM4E (0.42) L3MBTL1CNR2KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877197-A C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases CONATUS PHARMACEUTICALS, INC. 1999-03-02 US disclosed